Position in PCRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$608
+$269 QoQ
Shares Held
24
+60.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#237
of 251 holders
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Elequin Capital, LP holds $7,829,403 across 8 Drug Manufacturers - Specialty & Generic names. PCRX ranks #5 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
223,068 | $7,733,767 | |
| 2 | HLN |
Haleon plc
|
5,397 | $50,354 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,228 | $41,604 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
26 | $2,152 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
This page
|
24 | $608 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
10 | $410 | |
| 7 | ZTS |
Zoetis Inc.
|
4 | $287 | |
| 8 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
11 | $221 |
All Filings in PCRX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $608 | 24 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $339 | 15 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,397 | 54 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $932 | 39 | Shares | Sole | 2025-08-11 | |
| 2024-12-31 | $75 | 4 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $3,717 | 247 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $204 | 7 | Shares | Sole | 2025-03-11 | |
| 2023-06-30 | $2,764 | 69 | Shares | Sole | 2023-08-14 | |
| 2022-06-30 | $12,359 | 212 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $17,935 | 235 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||